Merz North America has received the green light from the Food and Drug Administration for Xeomin (incobotulinumtoxinA) for the treatment of chronic sialorrhea, or excessive drooling, in adult patients.
Although GlaxoSmithKline said it has developed a “fair and equitable” process to ship Shingrix, its new shingles vaccine, two U.S. senators are urging the drugmaker do more to boost inventory levels in the wake of a shortage.
Catalent, a leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, is acquiring Juniper Pharmaceuticals.
Epidiolex (cannabidiol, or CBD, oral solution) is indicated to treat two rare forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients 2 years old and older.
Nicholas Hart joins Lupin from Ferring Pharmaceuticals as Lupin launches Solosec, a treatment for bacterial vaginosis developed by its recently acquired subsidiary Symbiomix Therapeutics.
The Phair Pricing Act of 2018 looks to make more transparent the prices that pharmacy benefit managers and prescription drug plan sponsors negotiate with pharmacies.